A "black box" warning on a health product sounds pretty scary—maybe even more so when it's suddenly being taken off the ...
This Viewpoint describes the U.S. Food and Drug Administration’s intended label updates and removal of black box warnings for menopausal hormone therapy based on current evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback